The FDA approved the first new drug for Alzheimer’s disease in nearly 20 years Monday, even though the decision to greenlight Biogen’s new drug has been fraught with controversy.
WBZ-TV's Mallika Marshall has more.
Groundbreaking Yet Controversial Alzheimer’s Drug Administered to First Patient
Veuer
It could be a game-changer for treating Alzheimer’s, but not all are convinced. Veuer’s Tony Spitz has the details.
